Ally Bridge Group as of Dec. 31, 2021
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 30 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera (NTRA) | 8.7 | $25M | 268k | 93.39 | |
Arvinas Ord (ARVN) | 6.6 | $19M | 230k | 82.14 | |
Repligen Corporation (RGEN) | 6.5 | $19M | 70k | 264.84 | |
Isoplexis Corp | 5.7 | $16M | 1.8M | 9.19 | |
Fate Therapeutics (FATE) | 5.5 | $16M | 270k | 58.51 | |
Cogent Biosciences (COGT) | 4.5 | $13M | 1.5M | 8.58 | |
Mirati Therapeutics | 4.4 | $13M | 85k | 146.69 | |
Miragen Therapeutics (VRDN) | 4.2 | $12M | 605k | 19.77 | |
Syros Pharmaceuticals | 4.0 | $12M | 3.5M | 3.26 | |
Sarepta Therapeutics (SRPT) | 3.8 | $11M | 120k | 90.05 | |
Guardant Health (GH) | 3.7 | $11M | 105k | 100.02 | |
Nuvation Bio Com Cl A (NUVB) | 3.6 | $10M | 1.2M | 8.50 | |
Ideaya Biosciences (IDYA) | 3.6 | $10M | 430k | 23.64 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 3.3 | $9.5M | 330k | 28.89 | |
Somalogic Class A Com | 3.3 | $9.3M | 800k | 11.64 | |
Iveric Bio | 3.2 | $9.2M | 550k | 16.72 | |
Nanostring Technologies (NSTGQ) | 2.7 | $7.8M | 185k | 42.23 | |
Iovance Biotherapeutics (IOVA) | 2.7 | $7.8M | 407k | 19.09 | |
Intellia Therapeutics (NTLA) | 2.7 | $7.7M | 65k | 118.25 | |
Nautilus Biotechnology (NAUT) | 2.2 | $6.3M | 1.2M | 5.18 | |
Sight Sciences (SGHT) | 2.1 | $6.0M | 342k | 17.57 | |
Leap Therapeutics | 2.1 | $5.9M | 1.8M | 3.24 | |
Gossamer Bio (GOSS) | 1.9 | $5.4M | 475k | 11.31 | |
Jounce Therapeutics | 1.7 | $4.8M | 575k | 8.35 | |
Rapid Micro Biosystems Class A Com (RPID) | 1.6 | $4.7M | 438k | 10.64 | |
Stoke Therapeutics (STOK) | 1.6 | $4.4M | 185k | 23.99 | |
Medavail Holdings Ord | 1.4 | $4.1M | 2.9M | 1.40 | |
Verve Therapeutics (VERV) | 1.4 | $4.1M | 110k | 36.87 | |
Cyteir Therapeutics | 1.3 | $3.6M | 320k | 11.37 | |
Macrogenics (MGNX) | 0.2 | $482k | 30k | 16.07 |